Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001.

MLA

Stephens, Deborah M., et al. “Extranodal Presentation in Limited-Stage Diffuse Large Bcell Lymphoma as a Prognostic Marker in Three SWOG Trials S0014, S0313 and S1001.” Haematologica, vol. 107, no. 11, Nov. 2022, pp. 2732–36. EBSCOhost, https://doi.org/10.3324/haematol.2022.281004.

APA

Stephens, D. M., Li, H., Constine, L. S., Fitzgerald, T. J., Leonard, J. P., Kahl, B. S., Song, J. Y., LeBlanc, M. L., Smith, S. M., Persky, D. O., & Friedberg, J. W. (2022). Extranodal presentation in limited-stage diffuse large Bcell lymphoma as a prognostic marker in three SWOG trials S0014, S0313 and S1001. Haematologica, 107(11), 2732–2736. https://doi.org/10.3324/haematol.2022.281004

Chicago

Stephens, Deborah M, Hongli Li, Louis S Constine, Thomas J Fitzgerald, John P Leonard, Brad S Kahl, Joo Y Song, et al. 2022. “Extranodal Presentation in Limited-Stage Diffuse Large Bcell Lymphoma as a Prognostic Marker in Three SWOG Trials S0014, S0313 and S1001.” Haematologica 107 (11): 2732–36. doi:10.3324/haematol.2022.281004.